These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6612294)

  • 1. [Pathophysiology of reperfusion of the ischemic myocardium].
    Wu GL
    Sheng Li Ke Xue Jin Zhan; 1983 Apr; 14(2):118-22. PubMed ID: 6612294
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of myocardial reperfusion.
    Fox KA; Saffitz JE; Corr PB
    Cardiol Clin; 1987 Feb; 5(1):31-48. PubMed ID: 3548974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of myocardial perfusion.
    Schaper W; Schaper J
    Pathobiol Annu; 1976; 6():317-63. PubMed ID: 798164
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrophysiologic, mechanical and ultrastructural changes on reperfusion in the dog heart.
    Sedek G; Beresewicz A; Elzanowski W; Wojtczak J
    Mater Med Pol; 1980; 12(4):244-51. PubMed ID: 7266050
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effect of temporary or permanent myocardial ischemia on cardiac function and pathology.
    Bolooki H; Rooks JJ; Viera CE; Smith B; Mobin-Uddin K; Lombardo CR; Jude JR
    J Thorac Cardiovasc Surg; 1968 Oct; 56(4):590-8. PubMed ID: 5683696
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ischemic cardiomyopathy (II). Physiopathologic mechanisms of ischemia and myocardial reperfusion].
    García-Dorado D; Fernández Avilés F
    Rev Esp Cardiol; 1988 Feb; 41(2):109-19. PubMed ID: 3285387
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage.
    Kloner RA; Ellis SG; Lange R; Braunwald E
    Circulation; 1983 Aug; 68(2 Pt 2):I8-15. PubMed ID: 6861331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of anoxia and ischemia on the ultrastructure and metabolism of the myocardium. Ultrastructure of the myocardium after ischemia and reperfusion].
    Schaper J
    Coeur Med Interne; 1979; 18(4):617-8. PubMed ID: 553760
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiological changes in different layers of the ventricular wall caused by 60-minute ligation of the coronary artery and reperfusion in the dog. II. In vitro studies of intracellular potentials].
    Beresewicz A; Sedek G
    Kardiol Pol; 1981; 24(4):287-303. PubMed ID: 7289369
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of hypertension and ischemic heart disease.
    Prys-Roberts C
    Int Anesthesiol Clin; 1980; 18(4):1-23. PubMed ID: 6450170
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of acute ischemia and reperfusion on the length-tension-velocity of myocardial contraction in an experimental model heart.
    Bolooki H; Fisher R; Jude JR
    Surg Forum; 1969; 20():156-7. PubMed ID: 5383035
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperosmolar reperfusion following ischemic cardiac arrest: Critical importance of the timing of mannitol administration on preservation of myocardial structure and function.
    Schaff HV; Goldman RA; Bulkley BH; Gott VL; Flaherty JT
    Surgery; 1981 Feb; 89(2):141-50. PubMed ID: 6779393
    [No Abstract]   [Full Text] [Related]  

  • 15. Recovery of left ventricular segmental function following temporary coronary occlusion.
    Bush LR; Buja LM; Samowitz W; Rude RE; Willerson JT
    Trans Assoc Am Physicians; 1982; 95():94-103. PubMed ID: 7182990
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of evolving myocardial infarction and failed PTCA.
    Beyersdorf F
    Ann Thorac Surg; 1995 Sep; 60(3):833-8. PubMed ID: 7677542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclocreatine inhibits neutrophil accumulation in the myocardium of a canine model of coronary artery occlusion and reperfusion.
    Elgebaly SA; Allam ME; Houser S; Hashmi F; Forouhar F; Miano D
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1670-7. PubMed ID: 8371165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiological alterations in ischemic myocardium].
    He RR
    Sheng Li Ke Xue Jin Zhan; 1980 Mar; 11(3):201-7. PubMed ID: 7268372
    [No Abstract]   [Full Text] [Related]  

  • 19. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphofunctional equivalents of superficial and extreme myocardial ischemia].
    Gavrish AS
    Vrach Delo; 1984 Feb; (2):45-8. PubMed ID: 6719870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.